Literature DB >> 17503139

Neuropsychiatric disease in collagen vascular diseases and vasculitis.

Peter Berlit1.   

Abstract

The prevalence of neuropsychiatric symptoms in systemic lupus erythematosus varies between 37 and 95%; cognitive dysfunction, mood disorder, and anxiety syndromes are especially frequent. In Sjoegren's syndrome, cognitive dysfunction is combined with frontal executive disorder and attention deficit. Memory impairment, frontal executive dysfunction and personality changes have been reported in Behçet's disease. Classic polyarteritis nodosa, the Churg Strauss syndrome and Wegener's granulomatosis may be associated with cognitive changes due to inflammatory encephalopathy. Cranial arteritis belongs to the treatable causes of dementia. In primary angiitis of the CNS, small-vessel disease presents more frequently with encephalopathy.

Entities:  

Mesh:

Year:  2007        PMID: 17503139     DOI: 10.1007/s00415-007-2021-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  8 in total

1.  Diagnosis and management of isolated angiitis of the central nervous system.

Authors:  P M Moore
Journal:  Neurology       Date:  1989-02       Impact factor: 9.910

2.  Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations.

Authors:  R Monastero; P Bettini; E Del Zotto; E Cottini; A Tincani; G Balestrieri; R Cattaneo; R Camarda; L A Vignolo; A Padovani
Journal:  J Neurol Sci       Date:  2001-02-15       Impact factor: 3.181

3.  Primary angiitis of the central nervous system: emerging variants.

Authors:  K MacLaren; J Gillespie; S Shrestha; D Neary; F W Ballardie
Journal:  QJM       Date:  2005-07-22

4.  Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.

Authors:  E Y McLaurin; S L Holliday; P Williams; R L Brey
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

5.  Neuropsychological follow-up of 12 patients with neuro-Behçet disease.

Authors:  O Oktem-Tanör; B Baykan-Kurt; I H Gürvit; G Akman-Demir; P Serdaroğlu
Journal:  J Neurol       Date:  1999-02       Impact factor: 4.849

6.  The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus.

Authors:  H Ainiala; J Loukkola; J Peltola; M Korpela; A Hietaharju
Journal:  Neurology       Date:  2001-08-14       Impact factor: 9.910

7.  Neurological complications of primary Sjögren's syndrome.

Authors:  C Lafitte; Z Amoura; P Cacoub; P Pradat-Diehl; C Picq; F Salachas; J M Léger; J C Piette; J Y Delattre
Journal:  J Neurol       Date:  2001-07       Impact factor: 4.849

8.  Neuropsychological function in systemic lupus erythematosus: a five-year longitudinal study.

Authors:  K Waterloo; R Omdal; G Husby; S I Mellgren
Journal:  Rheumatology (Oxford)       Date:  2002-04       Impact factor: 7.580

  8 in total
  5 in total

1.  Diagnosis and treatment of cerebral vasculitis.

Authors:  Peter Berlit
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

Review 2.  Cerebral vasculitis in adults: what are the steps in order to establish the diagnosis? Red flags and pitfalls.

Authors:  P Berlit; M Kraemer
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

Review 3.  The emerging link between autoimmune disorders and neuropsychiatric disease.

Authors:  Matthew S Kayser; Josep Dalmau
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2011       Impact factor: 2.198

4.  A man with small vessel vasculitis presenting with brachial diplegia, multiple cranial mononeuropathies and severe orthostatic hypotension in diabetes mellitus: a case report.

Authors:  Sahar F Zafar; Jerry Clay Goodman; Eroboghene E Ubogu
Journal:  J Med Case Rep       Date:  2013-10-01

5.  Vascular cognitive impairment in Pemphigus vulgaris: A case report.

Authors:  José Ibiapina Siqueira-Neto; Paulo Marcelo Gondim Sales; Emmanuelle Silva Tavares Sobreira; Aline Miranda Limeira; Heline Bessa Araujo; Júnia Vieira Dos Santos; José Daniel Vieira de Castro
Journal:  Dement Neuropsychol       Date:  2012 Jul-Sep
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.